Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.
Assessing Diagnostic Value of Non-Invasive FFRCT in Coronary Care
The objective of the HeartFlow ADVANCE registry is to evaluate utility, clinical outcomes, and resource utilization of non-invasive FFRCT guided evaluation in clinically stable, symptomatic patients with coronary artery disease (CAD) in order to further inform patients, healthcare providers and other stakeholders about which technologies are most effective and efficient in the diagnosis and management of CAD.
Who may be Eligible
Clinical stable, symptomatic patients who undergo a cardiac CT scan (cCTA) and are diagnosed with CAD, and meet eligibility criteria for FFRCT.